Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Announces International Medical Supply Chain Agreement for COVID-19 Testing Kits and FDA Registered Suppliers of Personal Protective Equipment (PPE)

Joint Venture Procures from Established Manufacturers with Reliable Supply and Logistics for US Medical Operations NEW YORK, NY, March 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...
March 25, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Launches Secure Good Health Outcomes Telehealth Application for Immediate Free Download

Parallax Announces Patented Telehealth Initiative to Help Healthcare Providers Better Communicate with Their Patients and Reduce ER Admissions NEW YORK, NY, March 25, 2020 (GLOBE NEWSWIRE) --...
March 23, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Announces Immediate Availability Point-of-Care COVID-19 Diagnostic Testing Kits, Personal Protection Equipment (PPE) and Medical Supplies

Company Benefits from Unique Chinese, Hong Kong, Macau Diagnostic Patent Rights, and Closes Deal to Help America Now NEW YORK, NY, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...
March 17, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Harvard In Tech and Parallax Health Sciences to Present Live Webinar “COVID-19 Testing, Telehealth, Technology and Data Driven Solutions” Wednesday, March 18th at 1 PM EDT

NEW YORK, NY, March 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company,...
March 16, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Receives Approval on its Registration Into U.S. Government's System for Award Management, (SAM)

Patented and FDA Approved Diagnostics Platform Subject of Application for Contract Grant with U.S. Center for Disease Control, (CDC) NEW YORK, NY, March 16, 2020 (GLOBE NEWSWIRE) -- via...
March 12, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Health Management Announces Immediate Availability of its Good Health Outcomes Remote Patient Monitoring Mobile Application for Doctors and Their Patients Within the United States

$8.3 Billion in Federal Emergency Funding from U.S. Congress Combined with Private Insurance Reimbursement Commitments Gives Boost to Telehealth Programs Addressing the COVID-19 Pandemic NEW...
March 11, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Diagnostics Announces Intent to Develop a Rapid Screening Test for COVID-19 on its Patented FDA 510(K) Approved Diagnostic Platform

Company will Partner to Accelerate The Deployment of Diagnostic Solutions Under Patent Protected Service Areas Including China, Hong Kong, India, and US NEW YORK, NY, March 11, 2020 (GLOBE...
February 24, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Provides Mid-Quarter Update

Company Eliminates $25 Million Contingent Liability and Focuses Toward Operating Growth Parallax Licensing Program Moving Forward on All Fronts NEW YORK, NY, Feb. 24, 2020 (GLOBE NEWSWIRE) -- via...
February 10, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Good Health Outcomes Mobile Application for Remote Patient Monitoring Now Available to Over 300,000 Patients in North America Through Existing Agreements

Critical Access Hospitals, Doctor Offices and Nursing Operations Contract with Parallax for Chronic Disease Management Capitalizing on New Reimbursement Landscape NEW YORK, NY, Feb. 10, 2020 (GLOBE...
January 02, 2020 07:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Health Sciences Engages Alston & Bird

New York, NY, Jan. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, today announced that it...

Next Page keyboard_arrow_right